Media Center
- No
-
Category
- Show all
- Press Release
- News Article
- PR Video
- CEO Story
- Title
- Author
- Time uploaded
- Views
- Likes
- 169
- CEO Story
- CEO Story H.C. WAINWRIGHT 2ND ANNUAL OPHTHALMOLOGY VIRTUAL CONFERENCE
- PharmAbcine
- 18 Aug 2022
- Views1250
- 0
- 168
- CEO Story
- CEO Story Bio International Convention 2022
- PharmAbcine
- 17 Jun 2022
- Views3188
- 0
- 167
- CEO Story
- CEO Story Vote for Korea Bioprocessing Excellence Awards at Biologics Manufacturing Korea 2022
- PharmAbcine
- 30 May 2022
- Views1789
- 0
- 166
- Press Release
- Press Release PharmAbcine to participate in Jefferies Global Healthcare Conference and BIO International Convention
- PharmAbcine
- 12 May 2022
- Views2281
- 0
- 165
- Press Release
- Press Release PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study
- PharmAbcine
- 27 Apr 2022
- Views2174
- 0
- 164
- Press Release
- Press Release PharmAbcine Strengthens Scientific Advisory Board with a World-Renowned Expert in Ophthalmology
- PharmAbcine
- 27 Apr 2022
- Views2120
- 0
- 163
- Press Release
- Press Release PharmAbcine Presents Updated Preclinical Data of Its Anti-VISTA Antibody Candidate at AACR 2022
- PharmAbcine
- 12 Apr 2022
- Views5259
- 0
- 162
- CEO Story
- CEO Story PharmAbcine to participate in BIO-Europe Spring 2022
- PharmAbcine
- 17 Mar 2022
- Views1847
- 0
- 161
- Press Release
- Press Release PharmAbcine to Present Updated Data of Its Anti-VISTA Antibody Candidate at AACR 2022
- PharmAbcine
- 9 Mar 2022
- Views2079
- 0
- 160
- Press Release
- Press Release PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial
- PharmAbcine
- 27 Feb 2022
- Views2688
- 0